SCHEMBL17761167

SCHEMBL17761167

Cn1nc(O)c2c(Cl)ccc(I)c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17621278 0.81 MEN1 (0.31) —
SCHEMBL17544386 0.79 PIK3CD (0.30) —
SCHEMBL17761168 0.77 PDE2A (0.30) —
SCHEMBL17616523 0.77 — —
SCHEMBL16006819 0.73 CRHR1 (0.38) —
SCHEMBL20430360 0.71 CYP3A4 (0.40) —
SCHEMBL20430136 0.71 CCR4 (0.35) —
SCHEMBL23653934 0.70 CNR2 (0.33) —
SCHEMBL23654214 0.70 — —
SCHEMBL13106193 0.62 MAPK8 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016033243-A9 ANTIRETROVIRAL AGENTS GILEAD SCIENCES, INC. (US) 2016-05-19 — — WO disclosed
Send feedback